TY - JOUR
T1 - Studies of Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) protein peptides specifically binding to human RBC
AU - Bermudez Quintero, Adriana Janneth
AU - Pinzón, Carlos Giovanni
AU - Curtidor Castellanos, Hernando
AU - Forero, Martha
AU - Vanegas Murcia, Magnolia
AU - Rodríguez, Jorge
AU - Patarroyo, Manuel Elkin
PY - 2008/2/6
Y1 - 2008/2/6
N2 - Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) peptides used in normal red blood cell (RBC) binding assays revealed that peptides 33426 (79NINILSSVHRKGRILYDSF97) and 33460 (777HKKREKSISPHSYQKVSTKVQ797) bound with high activity, presenting nanomolar affinity constants. Such high binding activity peptides (HABPs) displayed helicoid and random coil structures as determined by circular dichroism. HABPs inhibited P. falciparumin vitro invasion of normal RBC by up to 61% (depending on concentration), suggesting that some RAMA protein regions could be involved in P. falciparum invasion of RBC. The nature and localisation of receptors on RBC surface responsible for HABP binding were studied using enzyme-treated erythrocytes and structural analysis
AB - Plasmodium falciparum rhoptry-associated membrane antigen (RAMA) peptides used in normal red blood cell (RBC) binding assays revealed that peptides 33426 (79NINILSSVHRKGRILYDSF97) and 33460 (777HKKREKSISPHSYQKVSTKVQ797) bound with high activity, presenting nanomolar affinity constants. Such high binding activity peptides (HABPs) displayed helicoid and random coil structures as determined by circular dichroism. HABPs inhibited P. falciparumin vitro invasion of normal RBC by up to 61% (depending on concentration), suggesting that some RAMA protein regions could be involved in P. falciparum invasion of RBC. The nature and localisation of receptors on RBC surface responsible for HABP binding were studied using enzyme-treated erythrocytes and structural analysis
UR - http://www.sciencedirect.com/science/article/pii/S0264410X07013072?via%3Dihub
U2 - 10.1016/j.vaccine.2007.11.086
DO - 10.1016/j.vaccine.2007.11.086
M3 - Research Article
SN - 0264-410X
VL - 26
SP - 853
EP - 862
JO - Vaccine
JF - Vaccine
IS - 6
ER -